Skip to Content
Merck
  • Purification and characterization of the Staphylococcus aureus bacillithiol transferase BstA.

Purification and characterization of the Staphylococcus aureus bacillithiol transferase BstA.

Biochimica et biophysica acta (2014-05-14)
Varahenage R Perera, Gerald L Newton, Jonathan M Parnell, Elizabeth A Komives, Kit Pogliano
ABSTRACT

Gram-positive bacteria in the phylum Firmicutes synthesize the low molecular weight thiol bacillithiol rather than glutathione or mycothiol. The bacillithiol transferase YfiT from Bacillus subtilis was identified as a new member of the recently discovered DinB/YfiT-like Superfamily. Based on structural similarity using the Superfamily program, we have determined 30 of 31 Staphylococcus aureus strains encode a single bacillithiol transferase from the DinB/YfiT-like Superfamily, while the remaining strain encodes two proteins. We have cloned, purified, and confirmed the activity of a recombinant bacillithiol transferase (henceforth called BstA) encoded by the S. aureus Newman ORF NWMN_2591. Moreover, we have studied the saturation kinetics and substrate specificity of this enzyme using in vitro biochemical assays. BstA was found to be active with the co-substrate bacillithiol, but not with other low molecular weight thiols tested. BstA catalyzed bacillithiol conjugation to the model substrates monochlorobimane, 1-chloro-2,4-dinitrobenzene, and the antibiotic cerulenin. Several other molecules, including the antibiotic rifamycin S, were found to react directly with bacillithiol, but the addition of BstA did not enhance the rate of reaction. Furthermore, cells growing in nutrient rich medium exhibited low BstA activity. BstA is a bacillithiol transferase from S. aureus that catalyzes the detoxification of cerulenin. Additionally, we have determined that bacillithiol itself might be capable of directly detoxifying electrophilic molecules. BstA is an active bacillithiol transferase from S. aureus Newman and is the first DinB/YfiT-like Superfamily member identified from this organism. Interestingly, BstA is highly divergent from B. subtilis YfiT.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
L-Glutathione reduced, BioXtra, ≥98.0%
Sigma-Aldrich
L-Glutathione reduced, ≥98.0%
Sigma-Aldrich
L-Glutathione reduced, suitable for cell culture, BioReagent, ≥98.0%, powder
Sigma-Aldrich
Mitomycin C from Streptomyces caespitosus, powder, contains NaCl as solubilizer
Sigma-Aldrich
Methanesulfonic acid solution, 4 M (with 0.2% (w/v) tryptamine)
Sigma-Aldrich
Cerulenin, ≥98% (HPLC), from Cephalosporium caerulens
Sigma-Aldrich
Ethidium bromide, ~95% (HPLC)
Sigma-Aldrich
Streptozocin, ≥75% α-anomer basis, ≥98% (HPLC), powder
Sigma-Aldrich
Mitomycin C from Streptomyces caespitosus, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Ethidium bromide, BioReagent, for molecular biology, powder
Sigma-Aldrich
Chlorobimane
Sigma-Aldrich
Ampicillin, anhydrous, 96.0-102.0% (anhydrous basis)
Sigma-Aldrich
Mitomycin C from Streptomyces caespitosus, meets USP testing specifications
Sigma-Aldrich
2-Methoxy-4-vinylphenol, ≥98%, FG
Sigma-Aldrich
Azithromycin
Supelco
trans-Ferulic acid, matrix substance for MALDI-MS, ≥99.0% (HPLC)
Ampicillin, anhydrous, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Ethacrynic acid, ≥97% (HPLC)
Supelco
Methanesulfonic acid, suitable for HPLC, LiChropur, ≥99.5% (T)
Ethacrynic acid, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Mitomycin C from Streptomyces caespitosus, ≥98% (HPLC), potency: ≥970 μg per mg (USP XXIV), γ-irradiated, suitable for cell culture
USP
Ampicillin, United States Pharmacopeia (USP) Reference Standard
Supelco
trans-Ferulic acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Methanesulfonic acid, ≥99.0%
Supelco
Ampicillin, analytical standard
Ferulic acid, European Pharmacopoeia (EP) Reference Standard
Azithromycin, European Pharmacopoeia (EP) Reference Standard